Mismatch Negativity Links to Information Processing in Multiple Sclerosis (MS) (P4.165)

CONCLUSIONS: Compared to matched controls, MS participants had blunted MMN which was associated with impaired SDMT performance. MMN may serve as a biomarker of cognitive impairment in MS. Disclosure: Dr. Jackson has nothing to disclose. Dr. Charvet has received personal compensation for activities with Biogen Idec as a consultant. Dr. Charvet holds stock and/or stock options in Johnson & Johnson. Dr. Amella has nothing to disclose. Dr. Proudfit has nothing to disclose. Dr. Krupp has received personal compensation for activities with Teva Neurosciences, Biogen Idec, EMD Serono, Betaseron/Bayer Healthcare Pharmaceuticals, Guidepoint Consultants, and Novartis. Dr. Krupp has received royalty payments from Genzyme Corporation, Bristol-Myers Squibb Company, Biogen Idec, and Johnson & Johnson. Dr. Krupp has received research support from EMD Serono and Biogen Idec.
Source: Neurology - Category: Neurology Authors: Tags: Cognition in Multiple Sclerosis Source Type: research